Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
Inhalation drugs are essential in the treatment of COPD, in controlling symptoms and preventing exacerbations. The aim of this pilot study is to collect data necessary for the planning of future efficacy trials. We plan to assess the value of providing training in inhalation technique to hospitalized COPD patients. Data on rehospitalizations will be collected from the hospital's medical records and from the National Patient Registry . The inhalation technique of all recruited patients will de assessed at baseline. The patients will then be randomised 1:1 to the intervention or standard care group. The intervention consists of a drug counselling, focusing on inhalation technique. In addition patients in the intervention group will have their medicines personally delivered from the hospital pharmacy at discharge (discharge service). Patients will be asked to fill in questionnaires evaluating the inhalation training and the discharge service
Interventions
OTHERInhalation technique training and discharge service
Patient drug counselling one-to-one, focusing on inhalation drugs and technique
Sponsors
Oslo University Hospital
Hospital Pharmacy Enterprise, South Eastern Norway
Oslo University College
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients admitted to the pulmonary ward, the Medical Department, Oslo University Hospital, Oslo, Norway
Exclusion criteria
Patients * previously included to the study * usually not administering their inhalation drugs themselves * using nebulizer chamber with their drug * who are contagious, thus restricting accessibility of personnel * who are not able to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to first readmission | One year after discharge of the last patient | Time to readmission based on data from the national patient registry |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in patient reported symptom score (CAT-score) from baseline to 2 months after discharge | 2 months after discharge | COPD assessment test (CAT) scores at baseline and 2 months after discharge. |
| Proportion of patients readmitted 3 months after discharge | 3 months | Based on the hospital records. Preliminary data to be published in a master thesis, as the data on the primary endpoint will be received too late |
Countries
Norway
Outcome results
None listed